Click Therapeutics granted FDA market authorization for digital migraine drug
Posted:
Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.
Researchers at McGill University have developed an AI tool that can identify rare groups of cells responsible for driving aggressive cancer progression. The tool, called SIDISH, offers a new way to distinguish which cells within a tumour are most strongly…
A new platform from Sophia Genetics is helping the health system improve genomic testing workflows and the quality of cancer care, the company says.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us